A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study

BACKGROUND: Studies have suggested the reduced effectiveness of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections with high vancomycin minimum inhibitory concentrations. Alternative agents such as daptomycin may be considered. We conducted a randomized cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalimuddin, Shirin, Chan, Yvonne F. Z., Phillips, Rachel, Ong, Siew Pei, Archuleta, Sophia, Lye, David Chien, Tan, Thuan Tong, Low, Jenny G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984763/
https://www.ncbi.nlm.nih.gov/pubmed/29859132
http://dx.doi.org/10.1186/s13063-018-2702-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984763/
https://www.ncbi.nlm.nih.gov/pubmed/29859132
http://dx.doi.org/10.1186/s13063-018-2702-8

Ejemplares similares